epurines.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | ePurines |
| Description | About ePurines, LLC is a drug development company focused on innovative purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases. The core technologies of the ePurines were developed in the VA labs and are patented by the US |
| Keywords | ePurines, drug development company, metabolic syndrome renal, innovative purinergic-based therapies |
Server Information
| WebSite | |
| Host IP | 3.33.152.147 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
epurines.com Valuation
|
US$2,721,447
Last updated: 2023-04-30 11:45:06
epurines.com has Semrush global rank of 3,889,220. epurines.com has an estimated worth of US$ 2,721,447, based on its estimated Ads revenue. epurines.com receives approximately 314,014 unique visitors each day. Its web server is located in United States, with IP address 3.33.152.147. According to SiteAdvisor, epurines.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,721,447 |
| Daily Ads Revenue | US$2,513 |
| Monthly Ads Revenue | US$75,364 |
| Yearly Ads Revenue | US$904,358 |
| Daily Unique Visitors | 20,935 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| epurines.com. | A | 600 | IP: 3.33.152.147 |
| epurines.com. | A | 600 | IP: 15.197.142.173 |
| epurines.com. | NS | 3600 | NS Record: ns33.domaincontrol.com. |
| epurines.com. | NS | 3600 | NS Record: ns34.domaincontrol.com. |
| epurines.com. | MX | 3600 | MX Record: 0 epurines-com.mail.protection.outlook.com. |
| epurines.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| epurines.com. | TXT | 3600 | TXT Record: MS=ms50829742 |
HtmlToTextCheckTime:2023-04-30 11:45:06
| Home Our People Technology Contact Search ePurines was founded by internationally recognized experts in purinergic signaling, and exclusively focuses on the development of purinergic signaling-based therapeutics. ePurines is developing innovative therapies targeting purinergic signaling in obesity, metabolic syndrome, and renal and liver diseases. ePurines’ genesis is linked to improving the Veterans health. The core technologies were developed and patented by the US Department of Veterans Affairs, and were licensed to ePurines . Vision & Strategy ePurines will create unique technological platforms in developing novel drugs that target purinergic signaling. The central strategy is to combine the state-of-the-art technology, innovation and skills of its scientists leading to patented drug targets in obesity, metabolic syndrome, renal and liver disease. ePurines ’ value proposition is leveraging its purinergic signaling platform and expertise to target diseases affecting US Veterans and |
HTTP Headers
HTTP/1.1 405 Not Allowed Server: awselb/2.0 Date: Sat, 23 Oct 2021 06:56:36 GMT Content-Length: 0 Connection: keep-alive WAFRule: HTTPMethodNOTAllowed |
epurines.com Whois Information
Domain Name: EPURINES.COM Registry Domain ID: 2063358747_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-10-04T17:37:38Z Creation Date: 2016-10-03T12:02:14Z Registry Expiry Date: 2021-10-03T12:02:14Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T18:31:52Z <<< |